观点：解开肌萎缩侧索硬化症的谜团。 - Suppr

Suppr

超能文献

Perspective: Untangling the ALS X-Files.

作者信息

Bedlack Richard

机构信息

University in Durham, North Carolina.

出版信息

Nature. 2017 Oct 18;550(7676):S122. doi: 10.1038/550S122a.

DOI:10.1038/550S122a

PMID:29045375

Abstract

摘要

相似文献

Perspective: Untangling the ALS X-Files.观点：解开肌萎缩侧索硬化症的谜团。

Nature. 2017 Oct 18;550(7676):S122. doi: 10.1038/550S122a.

Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症的补充和替代疗法

Neurol Clin. 2015 Nov;33(4):909-36. doi: 10.1016/j.ncl.2015.07.008. Epub 2015 Sep 8.

Experience of complementary and alternative medicine in patients with amyotrophic lateral sclerosis and their families: A qualitative study.肌萎缩侧索硬化症患者及其家属使用补充和替代医学的经验：一项定性研究。

Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):191-7. doi: 10.3109/21678421.2015.1125504. Epub 2016 Jan 6.

Experience of services as a key outcome in amyotrophic lateral sclerosis (ALS) care: the case for a better understanding of patient experiences.将服务体验作为肌萎缩侧索硬化症（ALS）护理的关键成果：更好理解患者体验的理由

Am J Hosp Palliat Care. 2012 Aug;29(5):362-7. doi: 10.1177/1049909111423774. Epub 2011 Oct 13.

Comprehensive management of amyotrophic lateral sclerosis.肌萎缩侧索硬化症的综合管理

Phys Med Rehabil Clin N Am. 1998 Feb;9(1):271-84, viii-ix.

Optimizing patient autonomy in amyotrophic lateral sclerosis: inclusive decision-making in multidisciplinary care.优化肌萎缩侧索硬化症患者的自主权：多学科护理中的包容性决策制定。

Neurodegener Dis Manag. 2014;4(1):1-3. doi: 10.2217/nmt.13.71.

Ethical aspects of unproved therapies in multiple sclerosis, amyotrophic lateral sclerosis, and other neurologic diseases.多发性硬化症、肌萎缩侧索硬化症及其他神经系统疾病中未经证实疗法的伦理问题。

Semin Neurol. 1984 Mar;4(1):83-6. doi: 10.1055/s-2008-1041534.

Living with amyotrophic lateral sclerosis/motor neurone disease (ALS/MND): decision-making about 'ongoing change and adaptation'.与肌萎缩性侧索硬化症/运动神经元病（ALS/MND）共存：关于“持续变化和适应”的决策。

J Clin Nurs. 2009 Mar;18(5):745-54. doi: 10.1111/j.1365-2702.2008.02671.x.

Motor cortex stimulation for amyotrophic lateral sclerosis. Time for a therapeutic trial?运动皮层刺激治疗肌萎缩侧索硬化症。是时候进行治疗试验了吗？

Clin Neurophysiol. 2004 Jun;115(6):1479-85. doi: 10.1016/j.clinph.2004.01.027.

Patient-centered decision making in amyotrophic lateral sclerosis: where are we?肌萎缩侧索硬化症中以患者为中心的决策制定：我们目前处于什么阶段？

Neurodegener Dis Manag. 2017 Dec;7(6):377-386. doi: 10.2217/nmt-2017-0026. Epub 2017 Nov 22.

本文引用的文献

How common are ALS plateaus and reversals?肌萎缩侧索硬化症的病情平稳期和病情逆转情况有多常见？

Neurology. 2016 Mar 1;86(9):808-12. doi: 10.1212/WNL.0000000000002251. Epub 2015 Dec 9.

Life-threatening misdiagnosis of bulbar onset myasthenia gravis as a motor neuron disease: How much can one rely on exaggerated deep tendon reflexes.球部起病的重症肌无力被误诊为运动神经元病危及生命：对亢进的深腱反射能有多大程度的依赖。

Adv Biomed Res. 2015 Feb 23;4:58. doi: 10.4103/2277-9175.151874. eCollection 2015.

ALSUntangled: introducing The Table of Evidence.解开肌萎缩侧索硬化症之谜：引入证据表。

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):142-5. doi: 10.3109/21678421.2014.987476. Epub 2014 Dec 27.

Where is the evidence? A systematic review of shared decision making and patient outcomes.证据何在？共享决策制定与患者预后的系统评价。

Med Decis Making. 2015 Jan;35(1):114-31. doi: 10.1177/0272989X14551638. Epub 2014 Oct 28.

No benefits from experimental treatment with olfactory ensheathing cells in patients with ALS.肌萎缩侧索硬化症患者接受嗅鞘细胞实验性治疗无获益。

Amyotroph Lateral Scler. 2010 May 3;11(3):328-30. doi: 10.3109/17482961003663555.

A case of celiac disease mimicking amyotrophic lateral sclerosis.

Nat Clin Pract Neurol. 2007 Oct;3(10):581-4. doi: 10.1038/ncpneuro0631.

The use of alternative medicine by patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者使用替代医学的情况。

J Neurol Sci. 2001 Oct 15;191(1-2):151-4. doi: 10.1016/s0022-510x(01)00615-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验